Seneca Biopharma Inc fka SNCA

[jugs]

Something isn't making sense to me. Shares have been under a bit of pressure of late but it's hardly a matter of everyone selling out, fearing the sky is falling. It wasn't many weeks ago that I picked up 500 additional shares at $3.04.I'll do it again if there's an opportunity to add in the $3.50-$3.65 range.

The following may be of help:
http://www.investor-edge.com/4432-INFI-02Jul2014.pdf

Neuralstem Inc.'s stock finished the Tuesday's session 4.98% lower at $4.01. A total of 1.37 million shares were traded, which was above its three months average volume of 1.12 million shares. The stock moved between $3.99 and $4.25 during the session. Over the last one month and the previous three months, Neuralstem Inc.'s shares have fallen by 6.74% and 5.42%, respectively. However, the company's stock has advanced 37.80% since the beginning of this year. The company's shares are trading above their 50-day and 200-day moving averages. Further, the stock's 50-day moving average of $3.99 is greater than its 200-day moving average of $3.30. Neuralstem Inc.'s stock has an RSI of 49.23.